Logo
x

Search category

Subscribe Now

Patients SEA

GSK's Nucala (mepolizumab) Receives FDA's Approval for its Two New Self-Administered Methods for Patients with SEA and EGPA

GSK's Nucala (mepolizumab) Receives FDA's Approval for its Two New Self-Administered Methods for Patients with SEA and EGPA

  • June 7, 2019
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.